Rehabilitation effect of Yunnan Baiyao on postoperative brain Protection in traumatic brain injury patients-A randomized placebo-controlled study based on standard treatmen

Department of Neurosurgery, The first medical center of the Chinese PLA General Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Acute TBI patients admitted within 8 hours of injury were enrolled in the study. They were diagnosed with acute moderate to severe TBI(Glasgow Coma Scale score on admission was 3 to 12)and without other important organs were injured .Intracranial brain contusion and laceration confirmed by head Computed tomography (CT)hematoma intracranial hematoma epidural or subdural hematoma and other clear organic lesions. Patients were included if they were between15 and 65 years of age, required emergency craniotomy and were operated on within 12 hours of injury.

•The exclusion criteria included severe multiple or combined injury patients, history of severe chronic illness,Participants in any other drug trial 1 month prior to the trial and during the trial period,had malignant tumor and other diseases of the nervous system and immune system,pregnant and lactating women,patients with blood transfusion of more than 400ml during treatment,Uncooperative, automatic discharge or death patients, patients who need a second craniotomy due to changes in their condition and any history of allergy to YNBY capsules.

发起方

Department of Neurosurgery, The first medical center of the Chinese PLA General Hospital